Full metadata record

DC Field Value Language
dc.contributor.authorKwak, Jin Ho-
dc.contributor.authorPark, Jun Yeon-
dc.contributor.authorLee, Dahae-
dc.contributor.authorKwak, Jae Young-
dc.contributor.authorPark, Eun Hwa-
dc.contributor.authorKim, Ki Hyun-
dc.contributor.authorPark, Hye-Jin-
dc.contributor.authorKim, Hyun Young-
dc.contributor.authorJang, Hyuk Jai-
dc.contributor.authorHam, Jungyeob-
dc.contributor.authorHwang, Gwi Seo-
dc.contributor.authorYamabe, Noriko-
dc.contributor.authorKang, Ki Sung-
dc.date.accessioned2024-01-20T08:04:08Z-
dc.date.available2024-01-20T08:04:08Z-
dc.date.created2021-09-02-
dc.date.issued2014-12-01-
dc.identifier.issn0960-894X-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/126008-
dc.description.abstractBecause of poor prognosis, clinical treatment of triple-negative (TN) breast cancer remains the most challenging factor in cancer treatment. Extensive research into alternative cancer therapies includes studying the naturopathic effects of the medicinal herb ginseng. This study investigates the anti-neoplastic properties of ginseng sapogenins and the derivatives: (1) (20(S)-protopanaxadiol (PPD), (2) 20(S)-protopanaxatriol), (3) (20(S)-dihydroprotopanaxadiol, and (4) 20(S)-dihydroprotopanaxatriol). These compounds were found to prevent the proliferation of MDA-MB-231 human breast cancer cells. PPD was the most potent inhibitor, exhibiting an IC50 (5.87 mu M) comparable to that of the chemotherapeutic drug taxol. Furthermore, PPD induced dose-dependent cleavage of caspase-8, caspase-3, and PARP in MDA-MB-231 cells. Thus, we propose that PPD acts as anti-cancer agent by stimulating caspase-dependent apoptosis in breast cancer cells. (C) 2014 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPergamon Press Ltd.-
dc.subjectGINSENOSIDES-
dc.subjectAPOPTOSIS-
dc.subjectCLEAVAGE-
dc.subjectRECEPTOR-
dc.subjectTHERAPY-
dc.subjectDEATH-
dc.titleInhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells-
dc.typeArticle-
dc.identifier.doi10.1016/j.bmcl.2014.10.041-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, v.24, no.23, pp.5409 - 5412-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.volume24-
dc.citation.number23-
dc.citation.startPage5409-
dc.citation.endPage5412-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000345125500013-
dc.identifier.scopusid2-s2.0-84910135809-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusGINSENOSIDES-
dc.subject.keywordPlusAPOPTOSIS-
dc.subject.keywordPlusCLEAVAGE-
dc.subject.keywordPlusRECEPTOR-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusDEATH-
dc.subject.keywordAuthorTriple-negative breast cancers-
dc.subject.keywordAuthorSapogenin-
dc.subject.keywordAuthorApoptosis-
dc.subject.keywordAuthorCaspase-
Appears in Collections:
KIST Article > 2014
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE